Cargando…

Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer

BACKGROUND: Estrogenic signals are suggested to have protection roles in the development of colorectal cancer (CRC). The G protein-coupled estrogen receptor (GPER) has been reported to mediate non-genomic effects of estrogen in hormone related cancers except CRC. Its expression and functions in CRC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qiao, Chen, Zhuojia, Jiang, Guanmin, Zhou, Yan, Yang, Xiangling, Huang, Hongbin, Liu, Huanliang, Du, Jun, Wang, Hongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418684/
https://www.ncbi.nlm.nih.gov/pubmed/28476123
http://dx.doi.org/10.1186/s12943-017-0654-3
_version_ 1783234088377778176
author Liu, Qiao
Chen, Zhuojia
Jiang, Guanmin
Zhou, Yan
Yang, Xiangling
Huang, Hongbin
Liu, Huanliang
Du, Jun
Wang, Hongsheng
author_facet Liu, Qiao
Chen, Zhuojia
Jiang, Guanmin
Zhou, Yan
Yang, Xiangling
Huang, Hongbin
Liu, Huanliang
Du, Jun
Wang, Hongsheng
author_sort Liu, Qiao
collection PubMed
description BACKGROUND: Estrogenic signals are suggested to have protection roles in the development of colorectal cancer (CRC). The G protein-coupled estrogen receptor (GPER) has been reported to mediate non-genomic effects of estrogen in hormone related cancers except CRC. Its expression and functions in CRC were investigated. METHODS: The expression of GPER and its associations with clinicopathological features were examined. The mechanisms were further investigated using cells, mouse xenograft models, and clinical human samples. RESULTS: GPER was significantly (p < 0.01) down regulated in CRC tissues compared with their matched adjacent normal tissues in our two cohorts and three independent investigations from Oncomine database. Patients whose tumors expressing less (n = 36) GPER showed significant (p < 0.01) poorer survival rate as compared with those with greater levels of GPER (n = 54). Promoter methylation and histone H3 deacetylation were involved in the down regulation of GPER in CRC cell lines and clinical tissues. Activation of GPER by its specific agonist G-1 inhibited proliferation, induced cell cycle arrest, mitochondrial-related apoptosis and endoplasmic reticulum (ER) stress of CRC cells. The upregulation of reactive oxygen species (ROS) induced sustained ERK1/2 activation participated in G-1 induced cell growth arrest. Further, G-1 can inhibit the phosphorylation, nuclear localization, and transcriptional activities of NF-κB via both canonical IKKα/ IκBα pathways and phosphorylation of GSK-3β. Xenograft model based on HCT-116 cells confirmed that G-1 can suppress the in vivo progression of CRC. CONCLUSIONS: Epigenetic down regulation of GPER acts as a tumor suppressor in colorectal cancer and its specific activation might be a potential approach for CRC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-017-0654-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5418684
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54186842017-05-08 Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer Liu, Qiao Chen, Zhuojia Jiang, Guanmin Zhou, Yan Yang, Xiangling Huang, Hongbin Liu, Huanliang Du, Jun Wang, Hongsheng Mol Cancer Research BACKGROUND: Estrogenic signals are suggested to have protection roles in the development of colorectal cancer (CRC). The G protein-coupled estrogen receptor (GPER) has been reported to mediate non-genomic effects of estrogen in hormone related cancers except CRC. Its expression and functions in CRC were investigated. METHODS: The expression of GPER and its associations with clinicopathological features were examined. The mechanisms were further investigated using cells, mouse xenograft models, and clinical human samples. RESULTS: GPER was significantly (p < 0.01) down regulated in CRC tissues compared with their matched adjacent normal tissues in our two cohorts and three independent investigations from Oncomine database. Patients whose tumors expressing less (n = 36) GPER showed significant (p < 0.01) poorer survival rate as compared with those with greater levels of GPER (n = 54). Promoter methylation and histone H3 deacetylation were involved in the down regulation of GPER in CRC cell lines and clinical tissues. Activation of GPER by its specific agonist G-1 inhibited proliferation, induced cell cycle arrest, mitochondrial-related apoptosis and endoplasmic reticulum (ER) stress of CRC cells. The upregulation of reactive oxygen species (ROS) induced sustained ERK1/2 activation participated in G-1 induced cell growth arrest. Further, G-1 can inhibit the phosphorylation, nuclear localization, and transcriptional activities of NF-κB via both canonical IKKα/ IκBα pathways and phosphorylation of GSK-3β. Xenograft model based on HCT-116 cells confirmed that G-1 can suppress the in vivo progression of CRC. CONCLUSIONS: Epigenetic down regulation of GPER acts as a tumor suppressor in colorectal cancer and its specific activation might be a potential approach for CRC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-017-0654-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-05 /pmc/articles/PMC5418684/ /pubmed/28476123 http://dx.doi.org/10.1186/s12943-017-0654-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Qiao
Chen, Zhuojia
Jiang, Guanmin
Zhou, Yan
Yang, Xiangling
Huang, Hongbin
Liu, Huanliang
Du, Jun
Wang, Hongsheng
Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
title Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
title_full Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
title_fullStr Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
title_full_unstemmed Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
title_short Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
title_sort epigenetic down regulation of g protein-coupled estrogen receptor (gper) functions as a tumor suppressor in colorectal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418684/
https://www.ncbi.nlm.nih.gov/pubmed/28476123
http://dx.doi.org/10.1186/s12943-017-0654-3
work_keys_str_mv AT liuqiao epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer
AT chenzhuojia epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer
AT jiangguanmin epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer
AT zhouyan epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer
AT yangxiangling epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer
AT huanghongbin epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer
AT liuhuanliang epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer
AT dujun epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer
AT wanghongsheng epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer